Cancer Communications (Oct 2022)

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool

  • Nicolas A. Fraunhoffer,
  • Analía Meilerman Abuelafia,
  • Nelson Dusetti,
  • Juan Iovanna

DOI
https://doi.org/10.1002/cac2.12335
Journal volume & issue
Vol. 42, no. 10
pp. 1028 – 1031

Abstract

Read online

No abstracts available.